Lpl Financial LLC Cassava Sciences Inc Transaction History

Lpl Financial LLC

$218 Billion
Q3 2024

A detailed history of Lpl Financial LLC transactions in Cassava Sciences Inc stock. As of the latest transaction made, Lpl Financial LLC holds 79,429 shares of SAVA stock, worth $191,423. This represents 0.0% of its overall portfolio holdings.

Number of Shares

79,429

Previous 62,108 27.89%

Holding current value

$191,423

Previous $767,000 204.69%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$9.57 - $35.08 $165,761 - $607,620	17,321 Added 27.89%	79,429 $2.34 Million
Q2 2024 Aug 07, 2024	BUY	$12.35 - $26.11 $54,302 - $114,805	4,397 Added 7.62%	62,108 $767,000
Q1 2024 May 10, 2024	BUY	$18.44 - $26.41 $31,145 - $44,606	1,689 Added 3.01%	57,711 $1.17 Million
Q4 2023 Feb 14, 2024	BUY	$12.64 - $30.11 $136,828 - $325,940	10,825 Added 23.95%	56,022 $1.26 Million
Q3 2023 Nov 13, 2023	BUY	$16.64 - $25.32 $10,366 - $15,774	623 Added 1.4%	45,197 $752,000
Q2 2023 Jul 31, 2023	SELL	$21.59 - $27.88 $160,586 - $207,371	-7,438 Reduced 14.3%	44,574 $1.09 Million
Q1 2023 May 10, 2023	BUY	$23.46 - $36.44 $227,937 - $354,051	9,716 Added 22.97%	52,012 $1.25 Million
Q4 2022 Feb 07, 2023	BUY	$27.82 - $44.16 $63,986 - $101,567	2,300 Added 5.75%	42,296 $1.25 Million
Q3 2022 Nov 14, 2022	SELL	$16.33 - $51.06 $65,662 - $205,312	-4,021 Reduced 9.14%	39,996 $1.67 Million
Q2 2022 Aug 12, 2022	BUY	$17.22 - $38.47 $120,264 - $268,674	6,984 Added 18.86%	44,017 $1.24 Million
Q1 2022 May 16, 2022	SELL	$32.6 - $53.05 $54,833 - $89,230	-1,682 Reduced 4.34%	37,033 $1.38 Million
Q4 2021 Feb 14, 2022	BUY	$36.77 - $90.91 $679,803 - $1.68 Million	18,488 Added 91.4%	38,715 $1.69 Million
Q3 2021 Nov 15, 2021	BUY	$41.79 - $135.3 $845,286 - $2.74 Million	20,227 New	20,227 $1.26 Million

Others Institutions Holding SAVA

# of Institutions

207

Shares Held

14M

Call Options Held

2.98M

Put Options Held

6.57M

View Full List

About CASSAVA SCIENCES INC

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $96.6M
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

More about SAVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Account

Lpl Financial LLC Cassava Sciences Inc Transaction History